Covid-19 Vaccine Update

Jeremy Hunt Excerpts

Thursday 4th February 2021 Commons Chamber

[Nadhim Zahawi]

I am grateful to the hon. Gentleman for his constructive way of engaging with the vaccination deployment programme. On trials, we have two running currently, both with Public Health England. The Vivaldi trial is testing residents of care homes, who were in category 1 of the JCVI categories. The second is Siren, which is testing frontline health workers, who are in category 2. As Jonathan Van-Tam, the deputy chief medical officer, has said, we will know the infection and transmission data from those trials in the next few weeks. Of course, the Oxford data is very promising—it needs to be peer reviewed—but those trials will also capture the Oxford vaccine, because obviously that came on site in January.

On the priority list, the JCVI looked very closely at both black, Asian and minority ethnic and, of course, other considerations, including by profession, and came down clearly on the side of age as the deciding factor in people’s risk of dying from covid. This is a race against death, hence the nine categories, which we are going through, and we will continue to do so. A number of professions will be captured in those categories. Of course, those with extremely severe illness will be captured in the category for the severely extremely vulnerable, and others will be captured in further categories down the phase 1 list.

I certainly think it would be wrong to change the JCVI recommendation, because categories 1 to 9 account for 99% of mortality. When we get into phase 2, we would welcome a debate and, of course, will ask the JCVI about including professions such as teachers, shop workers and police officers, who through their work come into contact with much greater volumes of the virus than others do, and it will advise us accordingly.

On BAME and ethnicity, the NHS now collects such data, and we are publishing it. We are doing an enormous amount of work not only across Government, but with the NHS, to ensure that we bring in local government so that we can begin to share data. I would welcome us working much closer with local government and the NHS so that we can identify, to the individual level, the people we need to protect as soon as possible.

I put it on the record that I want clinical commissioning groups to share data with MPs. Several colleagues—[Interruption.] Including you, Madam Deputy Speaker; I can see you nodding away vigorously. CCGs should and must engage with local politicians, because MPs get a lot of emails and telephone calls from concerned constituents in the top four most vulnerable categories. Of course, the NHS has plans to publish CCG-level data very soon.

As for care home staff, we had a fantastic response through the care home vaccination programme, which is category 1, and we continue to do more with staff to encourage them to be vaccinated, because we make four visits into care homes. Visit one is for the first dose, visit two is to try to vaccinate those who may have been infected the first time, because people cannot be vaccinated until after 28 days, visit three will be for second doses, and so on. We are getting greater traction with care home staff, but the hon. Gentleman is right to mention that. There is a big focus on helping them to go to hospital hubs and, of course, their primary care networks.

On the second dose, everyone who has had a first dose of Pfizer will get a second dose of Pfizer within that 12-week dosing period. That will begin in March in the usual way that the NHS does vaccinations. Everyone who has had a first dose of Oxford-AstraZeneca will get a second dose of Oxford-AstraZeneca within 12 weeks as well.

The hg is right to ask about people wanting the option of going either to a national vaccination centre or to the PCN. If right hon. and hon. Members have particular cases, please point them to us and we will do everything we can to ensure that that is facilitated.

The hon. Gentleman rightly highlighted HIV clinics. I will take that matter away and see whether there is a workaround for those who want to have that information remain private from their GP. We will see what we can do.

This is World Cancer Day, and there is now real excitement in the scientific community in the UK about the messenger RNA vaccine, because people can begin to think about vaccines for cancers as well. However, the hon. Gentleman raises an important point about those who care for the clinically extremely vulnerable, and we want to ensure that we deliver the JCVI phase 1 and then very quickly reach the rest of the population.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I congratulate the Minister on his leadership of the vaccine roll-out programme, which really is one of the most impressive anywhere in the world. Indeed, I also commend the Health Secretary for the foundations that he laid last year.

Now that we know that mutations and variants are the name of the game, I want to ask the Minister about a worst-case scenario: a variant that is wholly immune to the vaccines that we are currently distributing. How possible is it that we could see that in the next few months in the UK? Has the Manaus variant, which people are particularly worried about, arrived here from Brazil? If we did see such a variant, what is the timescale not just to develop a new vaccine that works against it, but to manufacture it and get it approved by regulators so that it is ready to go?

[Nadhim Zahawi]

I am grateful to the Chair of the Health and Social Care Committee for his question, and he is absolutely right. The manufacturers are already working on variants to their vaccine to take into account the mutation of the virus. Viruses will mutate to survive and this virus is no different. There are about 4,000 mutations now around the world, some more concerning than others. We have, in the United Kingdom, a genome sequencing industry that is a world leader—about 50%, or just under, of the sequencing has taken place in the United Kingdom. Not only are we working with the current manufacturers—Pfizer-BioNTech, AstraZeneca and Moderna —that have been approved, but we are also looking at how we can make sure that we make the most of the new messenger RNA technology, which allows the rapid development of vaccine variants that will then deal with the virus variants as rapidly as possible. When I spoke to the Science and Technology Committee a few weeks ago, I said that we were planning to have in place the ability to go from the moment that we can sequence a variant that we are really concerned about to the moment that we can have a vaccine ready in between 30 to 40 days, with then, of course, the manufacturing time.

We have invested in Oxfordshire, in the Vaccines Manufacturing and Innovation Centre, and in the Cell and Gene Therapy Catapult Manufacturing Innovation Centre in Braintree—£127 million there and just shy of £100 million in Oxfordshire—to be ready to manufacture any vaccine that we would need. The Prime Minister, of course, also visited those making what I refer to as our seventh vaccine, the Valneva vaccine. That is a whole inactivated virus, so it does not just work on the spikes in the way that the two current vaccines that we are deploying work. It works on the whole of the virus, which is much more likely to capture any mutations from the spikes and therefore be incredibly effective. We have invested in that production facility in Scotland so that we can have that vaccine as a future-proofing of annual vaccination strategies or a booster in the autumn, if necessary.

Covid-19 Update

Jeremy Hunt Excerpts

Tuesday 2nd February 2021 Commons Chamber

[Matt Hancock]

To answer the hon. Gentleman’s many questions, he is absolutely right to raise the importance of coming down hard on the cases of new variants that we have discovered here in the UK. These are cases that have been seen over the past two months. The action that we are putting into place is to make sure that we stop further spread, and further spread in the community, alongside the action taken to ensure that there is no spread from those who have a history of international travel. As he knows, we have brought in tougher action at the border and we stand ready to do more.

The hon. Gentleman asks for the SAGE minutes to be published. They are published regularly. He also asks about the neighbouring postcodes to those where a new variant case has been found, where it is a new variant of concern. We absolutely do that where it is epidemiologically sensible. For instance, if the case is found on the border of a postcode, obviously we go across that border. We also investigate linked premises—for instance, if somebody had a child at a school or is going to work in a particular workplace—and, working with the director of public health, we will ensure that testing is directed there as well.

The hon. Gentleman raises the issue of isolation payments. We have the £500 isolation payment in place, so nobody should, as he put it, go hungry because they have to isolate. What is critical in these areas is that people stay at home unless they absolutely have to go out. It is imperative that people follow the rules to get these new variants completely under control.

He asks about the care home success. I am delighted that we have been able to reach so many care homes. I said in my statement that we have reached 10,307 care homes in England. There are 110 care homes where the vaccination programme is still outstanding because they have had outbreaks and, for clinical reasons, the vaccination programme cannot start there, but it will as soon as it is clinically possible.

The hon. Gentleman also asks about the data being shared from the vaccination programme. That data is now routinely shared with local directors of public health, precisely for the reasons that he set out—so we can reach more parts.

Finally, he ends on the question of education. Of course we understand how challenging the impact of this lockdown is on those with children who have to be schooled at home. That is why the Prime Minister said that schools should be the first thing to open when it is safe and possible to do so. Sadly, that time is not yet, but the more that we all follow the rules that we have set out so clearly, the quicker that time will come.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I thank the Health Secretary for liaising with me on the issues in Surrey over the weekend, where the actions taken by him and the outstanding leader of Surrey County Council, Tim Oliver, are absolutely right. My right hon. Friend mentioned that, at the weekend, we reached the milestone of offering the vaccine to everyone in care homes, except for where there has been an outbreak. Does he agree that we should crown that tremendous achievement by making 2021 a year as significant for the social care sector as 1948 was for the NHS—the year it was founded—with a long-term financial settlement implementing Dilnot and setting it up for the future with a 10-year plan?

[Matt Hancock]

My right hon. Friend knows that we set out in our manifesto, committed in the manifesto and were elected on a manifesto to resolve the long-standing problems in social care. The Prime Minister has set out to the Liaison Committee, of which my right hon. Friend is a member, the timetable on which he hopes that we are able to deliver that commitment. Alongside dealing with this pandemic, we are working to deliver our manifesto commitments, whether on social care or the 40 new hospitals or the 50,000 more nurses. I look forward to being held to account by the Select Committee on Health and Social Care on those commitments.

Vaccine Roll-out

Jeremy Hunt Excerpts

Thursday 21st January 2021 Commons Chamber

[Mr Speaker]

Let us head to Surrey with the Chair of the Select Committee, Jeremy Hunt.

[Jeremy Hunt (South West Surrey) (Con) [V]]

Thank you, Mr Speaker. This week the Office for National Statistics said that prevalence rates nearly doubled during the November lockdown, and today’s REACT—real-time assessment of community transmission—study says that infections are still rising. Is not the reality that these new strains are massively more dangerous and harder to control than many realise? If we are going to bring down the horrific death rates that we are now seeing, should we not secure our border, with quarantine hotels, end household mixing outside bubbles, and follow Germany in mandating FFP2—filtering face piece—masks in shops and on public transport, to give better protection to wearers?

[Matt Hancock]

We have looked at the question of personal protective equipment with respect to the new variant, and the clinical advice I have received is that the current guidelines are right and appropriate. On international travel, as my right hon. Friend knows, we brought in significant measures last week to close the travel corridors, and we remain vigilant on what we need to do to guard against new variants coming in from abroad. The new variants do change this question, because it is about ensuring not just that we do not get extra cases coming in from abroad—in which case, if an area of a country has a lower case rate than us, there is no more risk than that of people staying in this country—but that new variants that might not be dealt with as effectively by the vaccine do not arrive and that we stop them coming. That is something on which have recently taken significant action, and of course we keep it under very close review.

Mental Health Act Reform

Jeremy Hunt Excerpts

Wednesday 13th January 2021 Commons Chamber

[Matt Hancock]

I welcome the comments of the SNP spokesman, and I appreciate her support and thoughtful questions. She is quite right about ensuring that we address the challenges that present themselves for people with autism who are, as she says, disproportionately likely to end up in the criminal justice system. This is an issue on which I have worked very closely with my right hon Friend the Lord Chancellor; I am delighted that he has been able to join us for this discussion.

Part of the point of separating the attitude in law towards those with mental ill health and those with learning disabilities and autism also relates to treatment when there is an interaction with the criminal justice system. It is absolutely critical to get this right. It is difficult, and a huge number of people are working very hard to get this right on the frontline, but at the moment they are hampered by the law when it comes to how that can happen. I hope that in the future they will be supported by the law such that they can make sure people get the right support and the right treatment, whether those people are in the criminal justice system or—as with the vast majority—they are law-abiding and need support from the state because they are in a vulnerable condition.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I thank my right hon. Friend for a comprehensive response to Sir Simon Wessely’s superb review, which I was proud to commission at the request of the former Prime Minister, my right hon. Friend the Member for Maidenhead (Mrs May), whose commitment to mental health issues has been unparalleled. However, he knows that changes in the law only matter insofar as they affect the lives of real people, and his Department’s own data says that we still have more than 2,000 people with autism and learning disabilities locked up in mental health units, often supposedly temporarily, and sadly sometimes experiencing terrible breaches of human rights, such as the frequent use of restraint.

Will my right hon. Friend use this landmark moment to follow what Italy has done and close down all such units, so that these highly vulnerable people can be looked after more humanely in the community?

[Matt Hancock]

Absolutely. I want to see more people cared for in appropriate settings, which will often be in the community. My right hon. Friend set the target, as Health Secretary, to reduce the number of people with autism and/or learning disabilities in secure in-patient care. The 2,000 figure that he cites is a significant reduction, I am glad to say, from when he set that target and set that work in train—almost half. I want that number to continue to fall.

Of course, where there is a criminal justice element or restriction, that can be more difficult. However, we must make sure that the treatment and setting are appropriate for each and every person. Very often, a mental health setting is not appropriate for somebody with learning disabilities or somebody with autism, for whom it can in fact be the opposite of appropriate; it could be the worst place.

My right hon. Friend will know, as the Chair of the Select Committee, that the Care Quality Commission has in fact closed a number of settings during the pandemic, and we must make sure that we build more capacity. We have the budget in the spending review to do that and some of that building work is under way. There is a huge programme of work on the physical estate side and on training staff, as the hon. Member for Tooting (Dr Allin-Khan) mentioned, as part of the legislative change. No one element of that transformation works without all the others.

Oral Answers to Questions

Jeremy Hunt Excerpts

Tuesday 12th January 2021 Commons Chamber

[Matt Hancock]

Of course, all these things are being looked at. The pressures on the NHS are very significant. I also want to say to people who have a healthcare condition that is not covid-related that they should come forward to the NHS. The promise of the NHS, of always treating people according to their clinical need and not ability to pay, is crucial. It is just as crucial in these pressured times as it is at any other time. If you find a lump or a bump, if you have a problem with your heart, or if there is a condition for which you need to come forward for urgent treatment, then the NHS is open and you must help us to help you. So, yes, we absolutely will do everything we possibly can to address the pressures, including looking at the measures the hon. Lady set out, but also let the message go out that, if you need the NHS for other conditions, please do come forward.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I congratulate my right hon. Friend on the speed of the vaccine roll-out and, in particular, his foresight in setting up the Vaccine Taskforce as far back as last April, which has made that possible. Personal thanks from my mum, who is getting her vaccine tomorrow at Epsom racecourse. Understandably, however, the public’s expectations about how quickly they will get their vaccine are now running well ahead of the system’s ability to deliver, causing floods of calls to GPs’ surgeries, which are already very busy. What can we do to set expectations among the public that getting to population-level immunity will be a marathon, not a sprint?

[Matt Hancock]

That is right. The Chair of the Health and Social Care Committee is wise to say that this will be a marathon, not a sprint. As of the early hours of this morning, we have vaccinated 39.9% of over-80-year-olds in England. We will reach all over-80-year-olds and ensure that they have the offer a vaccine in the coming weeks, and we will reach all of the top four priority groups by 15 February. We are on track and I am confident that we will deliver that. The other message that my right hon. Friend will perhaps help all of us to pass on to all his constituents, including his mum, is that the NHS will get in contact with them and offer them an appointment. That is the best and fairest way in which we can get the roll-out happening.

Covid-19: Vaccinations

Jeremy Hunt Excerpts

Monday 11th January 2021 Commons Chamber

[Madam Deputy Speaker (Dame Eleanor Laing)]

We now go to the Chairman of the Health and Social Care Committee, Jeremy Hunt.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I congratulate the Minister on getting this programme off to a flying start: to vaccinate 2 million people, including a third of over-80s, six weeks after the first dose was approved is an extraordinary achievement unmatched by any similar country. May I ask him about the speed of the roll-out? Many people want teachers to be jabbed as quickly as possible, but is it the case that all those in groups 1 to 4 will need their second jabs before we can make real inroads into other key groups? And will he publish the breakdown of numbers vaccinated not just by region but by local authority area, because a lot of people would like to know just how many people have been vaccinated in their local area?

[Nadhim Zahawi]

I am grateful for my right hon. Friend’s compliment and this is only the start. I hope that, as we progress in the weeks and months to come, the focus and the rate of output will continue to rise.

My right hon. Friend raises an important point around the critical workforce for the economy, like teachers. The Joint Committee on Vaccination and Immunisation looked at all these issues and has come out very clearly in favour of us vaccinating the nine cohorts that are most vulnerable to dying from covid-19, hence why that is absolutely our focus.

We are absolutely committed to making sure that people get two doses, so if they have received their Pfizer first dose, they will get their Pfizer second dose within 12 weeks of the first dose. Similarly, if they have had their AstraZeneca first dose, they will get their AstraZeneca second dose within 12 weeks. So those people whom we will begin to reach in March, where we have to deliver their second dose, will absolutely get their second dose. But to my right hon. Friend’s point, the more vaccine volumes that will come, and we have tens of millions that will come through beyond February and into March, the faster we can begin to protect those nine categories in phase 1. The moment we have done that, then it is absolutely right that we should begin to look at categories like teachers and police officers—those who may be exposed in their workplace to the risks of this virus.

Of course, it is worth reminding the House that it is two weeks after the first dose, and three weeks after the first dose with AstraZeneca, that people begin to get that protection, not the moment they are jabbed, so there is that lag time as well. But my right hon. Friend’s point is well made: we need to make sure, as we protect greater and greater numbers of people in those nine categories, that we then move very quickly to the next dose.

Covid-19 Update

Jeremy Hunt Excerpts

Wednesday 30th December 2020 Commons Chamber

[Mr Speaker]

Let us head to Surrey and the Chair of the Health Committee, Jeremy Hunt.

[Jeremy Hunt (South West Surrey) (Con)]

The news from AstraZeneca is fantastic. The Secretary of State and British science in general deserve enormous credit.

The NHS is now busier than last April; in parts of London it looks like it may fall over. However, back in April, schools were shut, but next week primary schools are due to reopen. In September, we came to regret allowing university students to go back en masse, but some universities will start to go back from next week. Why, in the middle of winter, when the NHS is under such pressure, when we have a dangerous new strain of the virus, are we taking such huge risks? Should not our entire focus for the next eight to 12 weeks be on saving lives, getting the first dose of the vaccine out to every single vulnerable person, stopping the NHS collapsing and putting NHS frontline staff at the front of the queue for the vaccines so that we keep safe the people upon whom our safety depends?

[Mr Speaker]

Order. Before the Secretary of State replies, may I remind Members who are not in the Chamber that they should have the same dress code even though they are virtual? It is only fair that we treat each other with the same respect.

Covid-19 Update

Jeremy Hunt Excerpts

Thursday 17th December 2020 Commons Chamber

[Matt Hancock]

The hon. Gentleman rightly asked about the arrangements in place for Christmas, which the Prime Minister set out yesterday very clearly. Christmas is a very special time of year and that is why we have put in the arrangements that we have. It is a matter of people’s personal responsibility to ensure that they act and see their loved ones in a way that is safe and careful. I think people understand that and, what is more, I think people will abide by it. We know that it is safer to see older people, especially if they are over 70 or clinically extremely vulnerable, if we have taken the care to reduce social contact beforehand. We also know that, after Christmas, being able to reduce social contact will be important for keeping this under control.

I think that aspect of personal responsibility is important. Sometimes in this House it feels to me that the debate is as though, if we do not, in Government, put in place concrete rules, nobody will take any action. Actually, it is down to individuals—each and every one of us—to take responsibility for our actions, within the rules, of course, but also being cautious. This is a massive team effort and my experience of the last few months is that when a community has come together to get case rates down, that is when it has happened and when it has worked. Even with the rules in place, it is only when the community essentially comes together to get this under control that we get cases coming down along with the pressure on the NHS. I regret having to take the action that we have to take. I deem it necessary, and there is a strong view right across Government that these actions are necessary, but I also plead that personal responsibility is absolutely central to how we as a society should respond to this pandemic.

The hon. Gentleman asked about the mass vaccination roll-out. The mass vaccination sites are appropriate for the Oxford/AstraZeneca vaccine, should that come through and be approved by the regulator, so it is some weeks until we will see those rolled out. However, we are every day having more and more primary care sites coming on board with the roll-out of the Pfizer vaccine, and it is very good to see that happening. I expect the numbers that are vaccinated to accelerate. The team have made a very good start and there is a long way further to go.

The hon. Gentleman asked about the data systems. They have largely been working very effectively. Of course, any very large logistical roll-out like this has niggles, but they are small and have been brilliantly dealt with locally on the ground.



The hon. Gentleman asked about the roll-out of testing in schools. As I say, the Education Secretary will set out more details on offering all secondary schools, colleges, special schools and alternative provision settings the help, support and facilities to test as many secondary-age and further education students as possible, as they resume their education in January. I thank in advance all the teachers and support staff in schools for their work; no doubt they will lean in and support this task to ensure that school return can be done as safely as possible.

Finally, I echo the hon. Gentleman’s words and wish him a happy and safe Christmas. I look forward very much to seeing him again in January.

[Jeremy Hunt (South West Surrey) (Con) [V]]

In the past week, I have received unexpectedly joyful emails from residents of South West Surrey who have been among the first in the world to receive a clinically approved vaccine for coronavirus. I thank my right hon. Friend for that early Christmas present. I also thank him for the energy, for the endless media rounds and for the dedication that he has shown in the past year, which must have been one of the toughest imaginable for a Health Secretary. I am also grateful that Waverley has been excluded from the Surrey-wide move to tier 3, in recognition of our lower infection rates, although we will remain vigilant.

I want to ask my right hon. Friend about Christmas, just a week away. Of course personal responsibility matters, but, in a pandemic, so does clarity. Irrespective of the law or the regulations, should we or should we not have indoor social gatherings with elderly and vulnerable family members?

[Matt Hancock]

People should act with great caution in this pandemic, because doing so protects them, protects their families and protects their loved ones. We have set out what the rules are, but they are not a limit up to which we should all push. We can all act within those rules to limit the spread, by reducing social contact in the days up to meeting a family member who may be, for instance, over 70—or any other family member. It is reasonable and responsible to take that sort of action.

I am grateful to my right hon. Friend for what he said about the vaccine roll-out. I have been cheered by the messages I get from constituents and others now that they are receiving the vaccine. We just have to ensure that we get the deployment out as fast as the vaccine can reasonably be produced and as fast as the NHS can deploy it, so that we get people the safety of that vaccine and so that we can get through this and out of this as soon as possible.

Covid-19 Update

Jeremy Hunt Excerpts

Monday 14th December 2020 Commons Chamber

[Matt Hancock]

I am glad to say that across large parts of the country there is very good evidence that tier 3 restrictions are working and the rates are coming down, but we need to be vigilant and, as the hon. Gentleman knows, overall rates are no longer coming down, hence we are having to take further action.

The hon. Gentleman talked in particular about the lessons from Liverpool; the primary lesson from Liverpool is that when everybody pulls together and everybody makes the sacrifices that are necessary for their whole community, we can really get this thing under control. I am grateful to colleagues across London and Essex and Hertfordshire, to whom I have been talking today, who are committed to working to ensure that we get the public health messages out first and foremost, and to the Mayor and the Conservative candidate for Mayor, who are both committed to working on behalf of the capital and, of course, those parts of Essex and Kent and Hertfordshire that are affected, because the single best thing that we can all do is speak with one voice about what is needed to get this virus under control.

The hon. Gentleman asked about Christmas, and my recommendation to people is to be cautious and careful. He asked about NHS funding and staffing; of course we have the strongest funding in history for the NHS, and I am delighted to say that we have more nurses in the NHS than ever before—14,000 more nurses than this time last year. I pay tribute to each and every one of them.

The hon. Gentleman asked about contact tracing and no doubt he will have seen the figures published on Thursday, which show that contact tracing now reaches over 80% of contacts. I pay tribute to the team, both local and national, who are ensuring that we can get to more than four fifths of people whom we need to reach, and that has been rapidly improving.

Finally, the hon. Gentleman asked about Fred, the gentleman with terminal cancer whom he spoke to this morning. Those with terminal cancer are, of course, clinically vulnerable by the nature of that awful disease, and we will ensure that those who are clinically vulnerable get access to the vaccine when clinically appropriate. I am very happy to take up the individual case he raises and ensure that Fred gets a fair deal.

All in all, I am grateful for the hon. Gentleman’s support for the measures we have outlined today and of course for the vaccine programme, which is rolling out across the country right now.

[Jeremy Hunt (South West Surrey) (Con)]

These are incredibly difficult decisions, but I wholly support them, because the evidence from all over the world is that acting early and decisively is the best way to save both lives and jobs. It would be perverse in the extreme if we were to take our foot off the pedal so close to rolling out the vaccine.

However, may I first ask the Secretary of State about the new strain? He said that it is highly unlikely that the vaccine will not work with a new strain. When will we know for sure? Are any trials going on? Will he get more up-to-date scientific information anytime soon?

Secondly, may I ask the Secretary of State for clarity? With just 11 days before Christmas, lots of people will be thinking about Christmas shopping. From Wednesday, will it be against the regulations for those living outside London to go to Oxford Street to do their Christmas shopping? Will that also be against the regulations for those living inside London? Is the only way legally to do Christmas shopping now to go online?

[Matt Hancock]

First, on my right hon. Friend’s question about the new variant, it is being assessed in Porton Down right now. As I said in my statement, the medical advice that we have is that it is highly unlikely that this new variant will impinge on the impact of the vaccine, but we will know that in the coming days and weeks as the new strand is cultured at Porton Down and then, of course, tests are conducted on it.

My right hon. Friend’s question about Christmas shopping is important. It is recommended that people should minimise travel, unless it is necessary, in a tier 3 area, and should minimise travel, unless it is necessary, to a tier 3 area. We have taken this action to try to protect people and to try to slow the spread of this virus, and that is absolutely the right thing to do.

Ockenden Review

Jeremy Hunt Excerpts

Thursday 10th December 2020 Commons Chamber

[Ms Dorries]

I thank the hon. Member for Ellesmere Port and Neston (Justin Madders) for his, as always, constructive and reasonable tone in his response. Yes, I can assure him that the resources are in place, and have been guaranteed to be in place. As for the deadline, it is 2021. I cannot give an exact month. It was really important to me—I believe that Donna Ockenden has mentioned this in her report a number of times— that the first 250 cases were evaluated so that we could take the learning from those cases and introduce it as quickly as possible. In that way, we could identify what had gone wrong so that we could prevent it from happening again in the future. That is why we have produced the report in two stages. We know the findings of this interim report and the recommendations that have been identified by Donna and her team can be put in place. The second stage of the report will appear before the end of next year—certainly in 2021. I will, as the hon. Gentleman requests, and personally if he requires it, update the House on what is happening with the report.

With regard to the maternity safety training fund, we secured £9.4 million in the spending review. It cannot be underestimated, in this time of covid, what a huge achievement that was. The money will not go into the old format of the maternity safety training fund, because we do not believe that that worked as well as it should have done. Much of that money was used to backfill the staff, who then, unfortunately, did not attend training. We did not get the best results—the biggest bang for the buck.

What we, as a Department, are doing now is directing that £9.4 million to where it is needed most and to where it can be spent in the most effective manner to produce results in maternity safety. That work is ongoing now in the Department, and I hope to be able to update the House and the hon. Gentleman very soon on how that money is being spent and what results we expect to see in return for the expenditure.

I did not anticipate the hon. Gentleman’s question about midwives. I do not have the exact number, because the figure rises every day. None the less, we are recruiting new nurses—I think the figure was 12,000 when I last gave a statement to the House—some of whom will be recruited to become midwives. So, yes, work is under way on the workforce and on nurse recruitment.

[Jeremy Hunt (South West Surrey) (Con)]

Babies’ skulls were fractured and bones were broken in excruciatingly traumatic births that would never have happened if mothers’ wishes had been listened to. This is an utterly shocking report, and I think the whole House is immensely grateful to Donna Ockenden and her team for such a thorough report, and to the Minister for taking it so seriously, as she always does.

Although much has improved in maternity safety in recent years, does the Minister agree that it is time to stamp out the “normal births” ideology, which says that there can be a debate or compromise about the total importance of a baby’s safety? That should always be paramount, and decisions on it should always be taken in consultation with the mother. The report team said they had

“the clear impression that there was a culture within The Shrewsbury and Telford Hospital NHS Trust to keep caesarean section rates low”.

That needs to stop—not just at Shrewsbury and Telford, but everywhere throughout the NHS. The biggest mistake in interpreting this report would be to think that what happened at Shrewsbury and Telford is a one-off, as it may well not be and we must not assume that it is.

Secondly, the report talks about the “injudicious use of oxytocin” to facilitate vaginal births that perhaps should not have been happening. Will the Minister look into that issue? Finally, this report happened because Rhiannon Davies and Richard Stanton, who lost their daughter Kate in 2009, and Kayleigh and Colin Griffiths, who lost their daughter Pippa in 2016, persuaded me that something needed to happen. Is it not shameful that we make it so hard for doctors, nurses and midwives in the NHS to speak out about tragedies that they see and that all the burden for change is left on the shoulders of grieving relatives? Is it not time, once and for all, to end the blame culture that we still have in parts of the NHS?

[Ms Dorries]

My right hon. Friend asked a number of questions that deserve answers, so please bear with me. His first point was about the number of caesarean sections and the thought or belief in the hospital that it was a good thing not to have them, which the report identifies.

The report shows us that there were years when C-sections at Shrewsbury and Telford were running at 11% and the national average was 24%, and at 13% when the national average was 26%. That demonstrates a lack of collegiate working between midwives, doctors and consultants. Most of the report’s recommendations show that, fundamentally, that is the problem: a lack of communication and an unwillingness to work with people—the medics, doctors, obstetricians and midwives. My right hon. Friend is absolutely right about intervention. There is the old saying, “Mother knows best”, but every woman should own her birth plan and be in control of what is happening to her during her delivery.

I give all thanks to my right hon. Friend, because this report is fundamental in terms of how it is going to inform maternity services across the UK going forward, not least because the NHS is working on an early warning surveillance system. What happened at Shrewsbury and Telford was that it was an outlying trust. As with East Kent and others, including Morecambe Bay, where we have seen issues, there has been an issue culturally; they are outlying, without the same churn of doctors, nurses, training or expertise. The NHS is now developing a system where we can pick up this data and know quickly where failings are happening.

Oxytocin is a drug used in the induction of labour to control the length, quality and frequency of uterine contractions. There are strict National Institute for Health and Care Excellence guidelines on the use of that drug. My right hon. Friend is correct: every trust should follow the guidelines. By highlighting that in this report, we will ensure that trusts are aware of those guidelines and that they are followed in future.